Veterinary Infectious Disease Diagnostic Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The veterinary infectious disease diagnostic market covers a broad range of products including immunoassays, molecular diagnostics, hematology and biochemistry analyzers, and consumables used to detect pathogens in animals. The market serves multiple segments including companion animals (dogs, cats, horses), livestock (cattle, swine, poultry), and aquaculture. Rapid diagnostic tests, laboratory-based assays, and imaging technologies all play roles in disease surveillance, treatment planning, and herd health management.

• •Encompasses immunoassay kits, PCR-based tests, ELISA systems, and point-of-care diagnostics for identifying animal pathogens
• •Serves companion animal clinics, livestock operations, diagnostic laboratories, and government animal health agencies
• •Includes services such as veterinary reference laboratory testing and on-farm diagnostic support

Rising global demand for animal protein is increasing pressure on livestock producers to monitor and control infectious diseases that threaten herd health and food safety. Growing pet ownership and higher spending on companion animal healthcare are expanding the addressable market for diagnostic testing in veterinary clinics. Additionally, the threat of zoonotic disease transmission, highlighted by events such as avian influenza outbreaks, has elevated government and industry investment in veterinary disease surveillance systems.

• •Increasing livestock production and intensification in emerging markets driving demand for herd-level disease monitoring
• •Rising companion animal healthcare spending and humanization of pets supporting growth in companion animal diagnostics
• •Government-mandated disease surveillance programs and trade regulations requiring documented testing for animal movements

The market is typically segmented by animal type, companion animals, livestock, and aquaculture, as well as by product type including immunodiagnostics, molecular diagnostics, and traditional microbiology. Geographically, North America and Europe hold the largest market shares due to well-established veterinary infrastructure and high companion animal care spending. The Asia-Pacific region represents the fastest-growing segment, fueled by expanding livestock sectors, rising disposable incomes, and increasing investment in veterinary healthcare across countries including China, India, and Southeast Asian nations.

• •North America leads in market share, supported by advanced veterinary hospital networks and high pet care expenditure
• •Asia-Pacific is the fastest-growing region, driven by intensifying livestock production and expanding companion animal markets
• •Livestock diagnostics account for the largest revenue share, while companion animal diagnostics grow at a higher rate due to premiumization trends

What are the recent trends and outlook?

The convergence of veterinary and human health surveillance, the One Health approach, is elevating the strategic importance of animal disease diagnostics in pandemic preparedness and antimicrobial resistance monitoring. Advances in rapid molecular testing, portable sequencing, and artificial intelligence-powered diagnostic interpretation are expected to accelerate detection times and improve disease management outcomes. As the market approaches projected values beyond $5 billion by the early 2030s, companies are likely to focus on integrated diagnostic platforms, telemedicine-supported testing, and expanded access to diagnostics in underserved regions.

• •One Health initiatives linking animal, human, and environmental health are driving increased investment in cross-sector disease surveillance
• •Point-of-care and rapid molecular diagnostics are gaining adoption as veterinary practitioners seek faster turnaround times
• •Antimicrobial resistance monitoring and stewardship programs are creating new demand for susceptibility testing and pathogen identification